Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers

By Huang Cheng-long   Yokomise Hiroyasu   Miyatake Akira  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 83-93

Future Medicine

Access to resources Recommend Favorite

In VivoStudies of Adenovirus-Based p53 Gene Therapy for Ovarian Cancer

By von Gruenigen V.E.   Santoso J.T.   Coleman R.L.   Muller C.Y.   Miller D.S.   Mathis J.M.  

Gynecologic Oncology, Vol. 69, Iss. 3, 1998-06 ,pp. : 197-204

Elsevier

Access to resources Recommend Favorite

Adenovirus-Based p53 Gene Therapy in Ovarian Cancer

By Santoso J.T.   Tang D-C.   Lane S.B.   Hung J.   Reed D.J.   Muller C.Y.   Carbone D.P.   Lucci II. J.A.   Scott Miller D.   Mathis M.J.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 171-178

Academic Press

Access to resources Recommend Favorite

Potential of Advexin^®®: a p53 gene-replacement therapy in Li––Fraumeni syndrome

By Nemunaitis Jackie M   Nemunaitis John  

Future Oncology, Vol. 4, Iss. 6, 2008-12 ,pp. : 759-768

Future Medicine

Access to resources Recommend Favorite

p53-Based Gene Therapy of Ovarian Cancer: Magic Bullet?

By Berchuck A.   Bast Jr. R.C.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 169-170

Academic Press

Access to resources Recommend Favorite